Intuitive Surgical Inc. (ISRG): Today's Featured Health Care Laggard

Intuitive Surgical was a leading decliner within the health care sector, falling $6.59 (-1.6%) to $415.54 on heavy volume
By TheStreet Wire ,

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Intuitive Surgical

(

ISRG

) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day up 0.4%. By the end of trading, Intuitive Surgical fell $6.59 (-1.6%) to $415.54 on heavy volume. Throughout the day, 767,760 shares of Intuitive Surgical exchanged hands as compared to its average daily volume of 426,000 shares. The stock ranged in price between $413.07-$425.00 after having opened the day at $423.00 as compared to the previous trading day's close of $422.13. Other companies within the Health Care sector that declined today were:

Mast Therapeutics

(

MSTX

), down 35.8%,

Verastem

(

VSTM

), down 11.1%,

Regulus Therapeutics

(

RGLS

), down 9.6% and

MiMedx Group

(

MDXG

), down 6.0%.

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Intuitive Surgical has a market cap of $17.1 billion and is part of the health services industry. Shares are down 13.9% year to date as of the close of trading on Tuesday. Currently there are 10 analysts that rate Intuitive Surgical a buy, 1 analyst rates it a sell, and 5 rate it a hold.

TheStreet Ratings rates

Intuitive Surgical

as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself.

On the positive front,

Organovo Holdings

(

ONVO

), up 16.4%,

Bovie Medical Corporation

(

BVX

), up 11.4%,

BG Medicine

(

BGMD

), up 9.9% and

Synthetic Biologics

(

SYN

), up 9.8% , were all gainers within the health care sector with

Celgene Corporation

(

CELG

) being today's featured health care sector leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care

(

RXD

).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null

Loading ...